16.03.2022 - NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) - Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet . Seite 1